Hepner et al., 1976 - Google Patents
Abnormal vitamin D metabolism in patients with cirrhosisHepner et al., 1976
- Document ID
- 13458554203309700072
- Author
- Hepner G
- Roginsky M
- Moo H
- Publication year
- Publication venue
- The American journal of digestive diseases
External Links
Snippet
To assess the role of hepatic function and alcohol on vitamin D metabolism, serum 25- hydroxyvitamin D (25-OHD) levels were measured in 20 healthy nonalcoholic control subjects, 31 “inactive” cirrhotics whose alcoholism was in remission, 8 alcoholic cirrhotics …
- 201000004044 liver cirrhosis 0 title abstract description 23
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P-C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hepner et al. | Abnormal vitamin D metabolism in patients with cirrhosis | |
| Medalle et al. | Vitamin D resistance in magnesium deficiency | |
| Harrell et al. | Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. | |
| Meys et al. | Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate | |
| Bell et al. | Evidence that increased circulating 1 α, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis | |
| Portale et al. | Physiologic regulation of the serum concentration of 1, 25-dihydroxyvitamin D by phosphorus in normal men. | |
| Drezner et al. | Osteomalacia due to 1α, 25-dihydroxycholecalciferol deficiency: association with a giant cell tumor of bone | |
| Nishiyama et al. | Decreased bone density in severely handicapped children and adults, with reference to the influence of limited mobility and anticonvulsant medication | |
| WALLING et al. | Effects of lα, 25-Dihydroxyvitamin D3 and Solanum Glaucophyllum on intestinal calcium and phosphate transport and on plasma Ca, Mg, and P levels in the rat | |
| Fraser et al. | Familial forms of vitamin D-resistant rickets revisited. X-linked hypophosphatemia and autosomal recessive vitamin D dependency | |
| Chesney et al. | Circulating vitamin D metabolite concentrations in childhood renal diseases | |
| Slovik et al. | Parathyroid hormone and 25‐hydroxyvitamin D levels in glucocorticoid‐treated patients | |
| Posner et al. | Effective 25-hydroxylation of vitamin D2 in alcoholic cirrhosis | |
| COUNTS et al. | Vitamin D intoxication in an anephric child | |
| Ringe | Vitamin D deficiency and osteopathies | |
| Finch et al. | Differential effects of 1, 25-(OH) 2D3 and 22-oxacalcitriol on phosphate and calcium metabolism | |
| KNORRING et al. | Serum levels of 25‐hydroxyvitamin D, 24, 25‐dihydroxyvitamin D and parathyroid hormone in patients with femoral neck fracture in southern Finland | |
| Hodsman et al. | Preliminary trials with 24, 25-dihydroxyvitamin D3 in dialysis osteomalacia | |
| Harrison et al. | Dihydrotachysterol: a calcium active steroid not dependent upon kidney metabolism | |
| Daum et al. | 25-Hydroxycholecalciferol in the management of rickets associated with extrahepatic biliary atresia | |
| Sinha et al. | Evidence for a defect in the formation of 1α, 25-dihydroxyvitamin D in pseudohypoparathyroidism | |
| Koshy | Vitamin D: an update | |
| JP3030854B2 (en) | Method for treating bone loss and method for preventing the same | |
| Keusch et al. | Ectopic ACTH syndrome and medullary thyroid carcinoma | |
| Pietrek et al. | Serum 25‐hydroxyvitamin D in patients with chronic renal disease |